Literature DB >> 1601988

Human autoantibodies against desmoplakins in paraneoplastic pemphigus.

J R Oursler1, R S Labib, L Ariss-Abdo, T Burke, E J O'Keefe, G J Anhalt.   

Abstract

Recently, a previously unrecognized autoantibody mediated blistering disease, paraneoplastic pemphigus has been described. Paraneoplastic pemphigus is associated with lymphoid malignancies, thymomas, and poorly differentiated sarcomas. Serum of affected patients contain pathogenic autoantibodies that immunoprecipitate from normal keratinocytes a characteristic complex of four polypeptides with M(r) of 250, 230, 210, and 190 kD. As our preliminary studies indicated that the 250-kD and the 210-kD antigens comigrated with desmoplakins I and II, we investigated the possibility that autoantibodies against the desmoplakins were a component of this autoimmune syndrome. 11 sera from affected patients were tested by indirect immunofluorescence against desmosome containing tissues, immunoprecipitation of metabolically labeled keratinocytes, and Western immunoblotting of desmoplakins I and II that had been purified to homogeneity from pig tongue epithelium. By indirect immunofluorescence, 9 of 11 sera showed strong binding to epithelial and nonepithelial desmosomes, and 2 were weakly reactive. All 11 immunoprecipitated 250- and 210-kD bands of variable intensity that comigrated with bands identified by a murine monoclonal antidesmoplakin antibody, and immunoblotting confirmed binding of the serum autoantibodies to purified desmoplakins. This demonstrates that paraneoplastic pemphigus is the first human autoimmune syndrome in which autoantibodies against the desmoplakins are a prominent component of the humoral autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601988      PMCID: PMC295873          DOI: 10.1172/JCI115781

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  CASE records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011.

Authors: 
Journal:  N Engl J Med       Date:  1954-01-07       Impact factor: 91.245

Review 2.  Desmosomes and hemidesmosomes: constitutive molecular components.

Authors:  M A Schwarz; K Owaribe; J Kartenbeck; W W Franke
Journal:  Annu Rev Cell Biol       Date:  1990

3.  Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome.

Authors:  S E Kornguth; T Kalinke; G B Grunwald; H Schutta; D Dahl
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

4.  Immunofluorescence localization of peripheral proteins in cultured human keratinocytes.

Authors:  A S Ma; A L Lorincz
Journal:  J Invest Dermatol       Date:  1988-03       Impact factor: 8.551

5.  Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.

Authors:  D M Neville
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

6.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

7.  Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration.

Authors:  J E Greenlee; H L Lipton
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

Review 8.  Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease. Report of three cases and review of the literature.

Authors:  H P Schlake; I W Husstedt; K H Grotemeyer; R Pötter
Journal:  Clin Neurol Neurosurg       Date:  1989       Impact factor: 1.876

9.  Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma.

Authors:  G B Grunwald; R Klein; M A Simmonds; S E Kornguth
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

10.  Desmoplakin II expression is not restricted to stratified epithelia.

Authors:  B D Angst; L A Nilles; K J Green
Journal:  J Cell Sci       Date:  1990-10       Impact factor: 5.285

View more
  13 in total

1.  Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.

Authors:  Shin Lee; Takahiro Yamauchi; Norito Ishii; Takashi Hashimoto; Keiichi Kinoshita; Shin Imamura; Kenichi Kamiya
Journal:  Int J Hematol       Date:  2017-08-08       Impact factor: 2.490

2.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

Authors:  M Amagai; T Nishikawa; H C Nousari; G J Anhalt; T Hashimoto
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

3.  The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.

Authors:  Isabelle Schepens; Fabienne Jaunin; Nadja Begre; Ursula Läderach; Katrin Marcus; Takashi Hashimoto; Bertrand Favre; Luca Borradori
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 4.  Autoantibodies against adhesion molecules and structures in blistering skin diseases.

Authors:  J R Stanley
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

Review 5.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

6.  Paraneoplastic Pemphigus: An Indication for Treatment in Chronic Lymphocytic Leukemia.

Authors:  Ifeanyichukwu Onukogu; Preethi Ramachandran; Joshua Narh; Sonu Sahni; Gardith Joseph
Journal:  Cureus       Date:  2020-05-27

Review 7.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

8.  Autoantibodies to desmoplakin I and II in patients with erythema multiforme.

Authors:  D Foedinger; G J Anhalt; B Boecskoer; A Elbe; K Wolff; K Rappersberger
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

9.  Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.

Authors:  Ahmad Yatim; Gérôme Bohelay; Sabine Grootenboer-Mignot; Catherine Prost-Squarcioni; Marina Alexandre; Christelle Le Roux-Villet; Antoine Martin; Eve Maubec; Frédéric Caux
Journal:  Front Med (Lausanne)       Date:  2019-11-05

Review 10.  Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis.

Authors:  Dario Didona; Luca Fania; Biagio Didona; Rüdiger Eming; Michael Hertl; Giovanni Di Zenzo
Journal:  Int J Mol Sci       Date:  2020-03-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.